The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous Keratopathy (C3R)

Mashhad University of Medical Sciences

Status: Completed

Conditions: Bullous Keratopathy

Treatments: Radiation: ultraviolet-A

Study type: Interventional

Funder types: Other

Identifiers

NCT01106274

MUMS-88191

Details and patient eligibility

About

Recently, riboflavin (0.1%) and ultraviolet-A (UVA) collagen cross-linking (C3R) has shown potential to improve the signs and symptoms of bullous keratopathy .The objective of this study is to demonstrate the effects of C3R to treat bullous keratopathy.

Enrollment: 20 patients

Sex: All

Ages: 20 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with bollous keratopathy

Exclusion criteria

• corneal scarring or contemporary eye disease affecting VA were excluded.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)